Business · 09/08/2000
FDA Releases Draft Guidance on Principles for Clinical Evaluation of New Antihypertensive Drugs
The FDA has made available a draft guidance document outlining the principles for evaluating new antihypertensive medications, developed in collaboration with the International Conference on Harmonisation, to ensure consistency in clinical trials across the globe.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →